Article Details

Fresh from $86M series A, Metis poaches Kala CSO to support move into the clinic - Fierce Biotech

Retrieved on: 2022-01-20 19:35:37

Tags for this article:

Click the tags to see associated articles and topics

Fresh from $86M series A, Metis poaches Kala CSO to support move into the clinic - Fierce Biotech. View article details on hiswai:

Excerpt

... China Life and Sequoia Capital China. The financing set Metis up to take a drug candidate into the clinic in 2022 and in-license programs, ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up